Austrian COVID-19 Registry

Last updated: November 26, 2020
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Overall Status: Active - Recruiting

Phase

N/A

Condition

Covid-19

Treatment

N/A

Clinical Study ID

NCT04351529
AGMT_COVID-19
  • Ages > 18
  • All Genders

Study Summary

The AGMT_COVID-19 Registry is designed as multicenter observational cohort of patients, that are tested positive for SARS-CoV-2. Data will be collected from all sites in Austria willing to participate.

Due to the non-interventional nature of the AGMT_COVID-19 registry, only routine data, which has already been recorded in the patient's medical chart, is transferred to the eCRF.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >=18 years
  • Positive test for SARS-CoV-2

Exclusion

Exclusion Criteria:

  • Due to the non-interventional design of the registry there are no specific exclusioncriteria.

Study Design

Total Participants: 1000
Study Start date:
April 01, 2020
Estimated Completion Date:
December 31, 2021

Study Description

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified at the end of 2019 in Wuhan, the capital of Hubei province in central China, and has since spread globally.

There are currently no authorised vaccines or treatments in the EU (European Union) to prevent or treat novel coronavirus disease (COVID-19) specifically or any other coronaviruses.

The AGMT_COVID-19 Registry is designed as multicenter observational cohort of patients, that are tested positive for SARS-CoV-2. Data will be collected from all sites in Austria willing to participate.

Due to the non-interventional nature of the AGMT_COVID-19 registry, only routine data, which has already been recorded in the patient's medical chart, is transferred to the eCRF. Treatment indication, the decision to offer treatment, treatment choice, dose, schedule and dose reductions/escalations, and response assessments shall be exclusively based on the risk/benefit estimation of the treating physician.

Connect with a study center

  • LKH Feldkirch: Innere Medizin II/ Interne E (Hämatologie und Onkologie)

    Feldkirch, 6807
    Austria

    Active - Recruiting

  • Kepler Universitätsklinikum Linz, Med. Campus III., Klinik für Lungenheilkunde / Pneumologie

    Linz, 4021
    Austria

    Active - Recruiting

  • IIIrd Medical Department, Private Medical University Hospital Salzburg

    Salzburg, 5020
    Austria

    Active - Recruiting

  • KH Zams: Innere Medizin Internistische Onkologie und Hämatologie

    Zams, 6511
    Austria

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.